NCT01285479
Who may be able to join
Who might be able to join this trial:
- You are a woman who has been diagnosed with Multiple Sclerosis (MS)
- You are currently pregnant
- You were taking a medication called fingolimod either during your pregnancy or up to 8 weeks before your last menstrual period
- You are willing to sign a consent form agreeing to take part
Who may not be able to join:
- There are no specific reasons that would prevent someone from joining this registry, as long as the above conditions are met
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Frequency of major malformations associated with exposure to fingolimod during pregnancy; Frequency of minor congenital malformations associated to fingolimod during pregnancy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.